Elsevier to Publish Czech Society of Cardiology Flagship Journal Cor et Vasa

WARSAW, Poland, March 15, 2012 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the Czech Society of Cardiology and Czech Society for Cardiovascular Surgery, announce the re-launch of journal Cor et Vasa.

Cor et Vasa is the official journal of the Czech Society of Cardiology, which was the first to publish breakthrough guidelines for the treatment of acute myocardial infarction recommending primary angioplasty as first choice therapy. It is open to all novel research in the field of cardiology and is recognized as a distinct international research forum gaining significant interest and contributions from all Central and Easter European countries.

Elsevier publishes Cor et Vasa in two versions; an English version accessible online only through SciVerse ScienceDirect, and a print version based on translations of the English articles to Czech. The Czech Society of Cardiology believes that this change will help re-introduce Cor et Vasa to the international medical community and to offer the journal as a publishing platform for researchers from other countries.

"With Cor et Vasa now published in two languages, we aim to reach out to a greater range of authors and readers based worldwide, not just in Eastern and Central Europe, and consequently to build a higher journal prestige for our local authors and the societies," Prof. Michael Aschermann, Editor-in-Chief of Cor et Vasa comments. "We hope that with the help and experience of Elsevier, Cor et Vasa will find its place amongst top journals within the field of cardiology."

"We are delighted to be launching such a prominent journal which throughout the years served as a unique forum for the exchange of knowledge," Ewa Kittel Prejs, Publishing Director Elsevier Poland said. "It is a pleasure to cooperate with highly renowned members of the society who make important international contributions to the development of medicine through publication of invaluable and milestones researches."

Cor et Vasa publishes research articles focusing on all core topics in cardiology, with a preference for clinical cardiology. Twice a year an issue will be dedicated to one key topic for which a high profile Guest Editor will be invited to ensure highest possible quality of the journal content.

For more information about the journal go to: http://www.elsevier.com/locate/crvasa.

About Cor et Vasa

Cor et Vasa publishes 6 times a year and covers all aspects of cardiology, angiology, cardiovascular surgery, cardiovascular imaging, pediatric cardiology, hypertension, cardiovascular prevention and some aspects of interventional radiology. It features editorials, review articles and original research as well as preliminary, fast-track and special communications (clinical and experimental).
The journal publishes in two versions with the same content: one being the on-line version of Cor et Vasa which is published in English only; the other printed version is largely in Czech (the manuscripts from the English version are translated into Czech by local experts).

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Ewa Kittel-Prejs
Elsevier
+48-509-997-930
[email protected]

SOURCE Elsevier

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED